Department of Anesthesiology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Division of Adult Cardiothoracic Surgery, University of California San Francisco, San Francisco, California, USA.
Thorax. 2019 Mar;74(3):219-228. doi: 10.1136/thoraxjnl-2018-211864. Epub 2019 Jan 12.
In acute respiratory distress syndrome (ARDS), pulmonary perfusion failure increases physiologic dead space ventilation (V/V), leading to a decline of the alveolar CO concentration [CO]. Although it has been shown that alveolar hypocapnia contributes to formation of atelectasis and surfactant depletion, a typical complication in ARDS, the underlying mechanism has not been elucidated so far.
In isolated perfused rat lungs, cytosolic or mitochondrial Ca concentrations ([Ca] or [Ca], respectively) of alveolar epithelial cells (AECs), surfactant secretion and the projected area of alveoli were quantified by real-time fluorescence or bright-field imaging (n=3-7 per group). In ventilated White New Zealand rabbits, the left pulmonary artery was ligated and the size of subpleural alveoli was measured by intravital microscopy (n=4 per group). Surfactant secretion was determined in the bronchoalveolar lavage (BAL) by western blot.
Low [CO] decreased [Ca] and increased [Ca] in AECs, leading to reduction of Ca-dependent surfactant secretion, and alveolar ventilation in situ. Mitochondrial inhibition by ruthenium red or rotenone blocked these responses indicating that mitochondria are key players in CO sensing. Furthermore, ligature of the pulmonary artery of rabbits decreased alveolar ventilation, surfactant secretion and lung compliance in vivo. Addition of 5% CO to the inspiratory gas inhibited these responses.
Accordingly, we provide evidence that alveolar hypocapnia leads to a Ca shift from the cytosol into mitochondria. The subsequent decline of [Ca] reduces surfactant secretion and thus regional ventilation in lung regions with high V/V. Additionally, the regional hypoventilation provoked by perfusion failure can be inhibited by inspiratory CO application.
在急性呼吸窘迫综合征(ARDS)中,肺灌注衰竭会增加生理无效腔通气(V/V),导致肺泡 CO 浓度 [CO]下降。虽然已经表明肺泡低碳酸血症有助于形成 ARDS 的典型并发症——肺不张和表面活性剂耗竭,但目前尚未阐明其潜在机制。
在离体灌注的大鼠肺中,通过实时荧光或明场成像(每组 3-7 个)来定量肺泡上皮细胞(AEC)的细胞质或线粒体 Ca 浓度 ([Ca]或[Ca])、表面活性剂分泌和肺泡的投影面积。在通气的新西兰白兔中,结扎左肺动脉并用活体显微镜测量亚肺气泡的大小(每组 4 个)。通过 Western blot 确定支气管肺泡灌洗液(BAL)中的表面活性剂分泌。
低 [CO] 降低了 AEC 中的 [Ca]并增加了 [Ca],导致 Ca 依赖性表面活性剂分泌和肺泡原位通气减少。用钌红或鱼藤酮抑制线粒体,阻断了这些反应,表明线粒体是 CO 感应的关键因素。此外,结扎兔肺动脉会减少体内肺泡通气、表面活性剂分泌和肺顺应性。向吸气气体中添加 5% CO 可抑制这些反应。
因此,我们提供了证据表明肺泡低碳酸血症会导致 Ca 从细胞质转移到线粒体。随后,[Ca]的下降会减少表面活性剂的分泌,从而减少高 V/V 区域的局部通气。此外,灌注衰竭引起的局部通气不足可通过吸气 CO 应用来抑制。